[HTML][HTML] … and health-related quality of life in the unstable angina patients with blood-stasis syndrome after percutaneous coronary intervention: a randomized controlled …

F Chu, J Wang, K Yao, Z Li - Chinese journal of integrative medicine, 2010 - Springer
… Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events
following percutaneous coronary intervention with paclitaxel eluting stents. J Psychosom Res …

PCI 治疗糖尿病患者左主干病变的临床研究.

张权宇, 刘海伟, 荆全民, 王效增… - Progress in Modern …, 2015 - search.ebscohost.com
… 摘要目的:研究经皮冠状动脉介入术(percutaneous coronary intervention,PCI)治疗合并冠状动脉
percutaneous coronary intervention versus coronary artery bypass graft surgery in patients

[PDF][PDF] 高龄冠状动脉CTO 患者PCI 治疗的可行性及安全性

张俊霞, 葛震, 王志梅, 许田, 叶飞, 田乃亮… - Age (yrs …, 2014 - biomed.cnjournals.com
… and drug-eluting stent use among patients >/=85 years of age in … percutaneous coronary
intervention versus coronary artery bypass grafting in patients with a mean age of >/=70 years

年龄对冠心病患者植入生物涂层可降解支架预后的影响

YU Le, LI Yi, LI Jing, W Lian-min… - Jie Fang Jun Yi Xue …, 2017 - search.proquest.com
percutaneous coronary intervention for acute coronaryPercutaneous coronary intervention
in the elderly: changes in case-mix and periprocedural outcomes in 31,758 patients treated …

[HTML][HTML] 经皮冠状动脉介入治疗术后支架内再狭窄患者血浆Rap1A 水平变化及其机制( 英文)

高浩东, 匡圆圆, 刘昱博, 张银妆, 王萍… - Journal of Central …, 2023 - ncbi.nlm.nih.gov
Percutaneous coronary intervention (PCI) is one of the most important treatments for
coronary artery disease (CAD). However, in-stent restenosis (ISR) after PCI is a serious …

中国老年患者经桡动脉与股动脉介入治疗比较

金辰, 徐奕, 乔树宾, 唐欣然, 吴永健… - Chinese Medical …, 2017 - cmsj.cams.cn
… 1229 patients aged over 65 years who underwent percutaneous coronary intervention (PCI) …
The dilemma of success: percutaneous coronary interventions in patients ≥ 75 years of age…

[PDF][PDF] 成功开通慢性完全闭塞冠状动脉病变血管能提高患者的生存率

林晓强, 朱海, 詹源胜 - 心脏杂志, 2013 - cpsmd.com.cn
… AIM:To study the effect of successful percutaneous coronary intervention(PCI)on the mor- …
in patients with chronic total occlusion(CTO).METHODS:Eighty—four CTO cases(12%) …

[PDF][PDF] 高龄(80-89 岁) 非ST 段抬高心肌梗死早期介入治疗的疗效观察

安伟帅, 尹巧香, 钟震宇, 刘峻松, 易军… - 现代生物医学 …, 2012 - biomed.cnjournals.com
… 摘要目的:研究调查高龄(80-89 岁)非ST 段抬高心肌梗死(non-ST-segment elevation myocardial
infarction, NSTEMI)患者行早期 经皮冠状动脉介入治疗(percutaneous coronary intervention , …

冠状动脉生物可降解支架设计与应用: 材料学的进一步革新将带来什么?

陈佳慧, 沈雳, 王齐兵, 葛均波 - 中国组织工程研究, 2014 - cjter.com
RESULTS AND CONCLUSION: The new fully biodegradable … the cardiac intervention, which
brings a new gospel for patients with … of a new era in percutaneous coronary and peripheral …

[PDF][PDF] 不同年龄急性冠脉综合征患者临床, CCTA 特点及近期预后分析

S Xiao-qing, S Shi-wei, S Jin-feng - CHINESE JOURNAL OF CT …, 2023 - diagnoschina.com
National trends and outcomes of percutaneous coronary intervention in patients70 years
of age with acute coronary syndrome (from the national inpatient sample database) [J].Am J …